We are live on
!
Find out more
SSA
SSA Swiss Advisors Portfolio holdings
AUM
$266M
1-Year Est. Return
24.57%
This Fund
S&P 500
This Quarter
Est. Return
+14.45%
1 Year Est. Return
+24.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$266M
AUM Growth
+$50.9M
(+24%)
Cap. Flow
+$28.4M
Cap. Flow
% of AUM
10.65%
Top 10 Holdings %
Top 10 Hldgs %
35.65%
Holding
113
New
19
Increased
25
Reduced
22
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$10.5M |
| 2 |
B
Barrick Mining
B
|
+$4.57M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$2.46M |
| 4 |
Microsoft
MSFT
|
+$1.91M |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$3.52M |
| 2 |
Merck
MRK
|
+$1.26M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$712K |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$301K |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$193K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 54.24% |
| 2 | Technology | 20.89% |
| 3 | Healthcare | 6.75% |
| 4 | Communication Services | 5.1% |
| 5 | Financials | 4.7% |
Similar funds
HBS
FOR
BWG
MH
DFG
FA
FCM
EW
SSA Swiss Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, SSA Swiss Advisors held 113 positions worth $266M, up 24% from $216M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
SSA Swiss Advisors deployed $28.4M of net new capital in Q2 2026, opening 19 new positions and adding to 25 existing holdings. Its largest new stake was SPDR Gold Trust: 25,372 shares worth $9.35M.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 55% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $1.26M trimmed.
- SSA Swiss Advisors's largest Q2 2026 buy was SPDR Gold Trust: 25,372 shares worth $9.35M.
- SSA Swiss Advisors added most to Invesco QQQ Trust in Q2 2026, an estimated $2.46M increase.
- SSA Swiss Advisors's biggest Q2 2026 reduction was Merck, cutting an estimated $1.26M.
- SSA Swiss Advisors fully exited Pfizer in Q2 2026, selling an estimated $3.52M.
- SSA Swiss Advisors's ten largest holdings make up 36% of its $266M portfolio in Q2 2026.
- SSA Swiss Advisors opened 19 new positions and closed 6 in Q2 2026.
- SSA Swiss Advisors's portfolio value rose 24% quarter-over-quarter to $266M.
Based on SSA Swiss Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.